AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3304473
Drug: Chemotherapy, radiotherapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy, radiotherapy, splenectomy, leukapheresis, monoclonal antibodies, immunomodulating agents
Trial: 31628854
Drug: Ubrogepant 400
RxNorm normalized name: Ubrogepant
DrugBank: Ubrogepant (DB15328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ubrogepant 400 mg
Trial: 29120908
Drug: Thiopurine treatment
RxNorm normalized name: thiotaurine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopurine treatment (discontinuation rate 22% in accepting group)
Trial: 29120908
Drug: Thiopurine treatment
RxNorm normalized name: thiotaurine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopurine treatment (steady-state metabolite levels)
Trial: 22385415
Drug: Diclofenac-tramadol combination
RxNorm normalized name: diclofenac, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac-tramadol combination (diclofenac 100 mg rectal suppository 8 hourly till 24 h + tramadol 75 mg intravenous 6 hourly)
Trial: 22385415
Drug: Diclofenac-acetaminophen combination
RxNorm normalized name: acetaminophen / diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac-acetaminophen combination (diclofenac 100 mg rectal suppository 8 hourly till 24 h + acetaminophen 1 g intravenous 6 hourly)
Trial: 22385415
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (diclofenac-tramadol and diclofenac-acetaminophen)
Trial: 10378323
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (200 IU dalteparin per kilogram body-weight per 24 hours), firm compression bandages, and encouraged walking
Trial: 8927235
Drug: Corticotropin-releasing hormone
RxNorm normalized name: corticotropin-releasing hormone
DrugBank: Corticorelin (DB05394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticotropin-releasing hormone (CRH) 100 micrograms
Trial: 8354332
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose (5 g)
Trial: 8354332
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose (15 g)
Trial: 8354332
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose (30 g)
Trial: 8354332
Drug: Intravenous glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glucose (35 g)
Trial: 8354332
Drug: Intravenous amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amino acids (10 g)
Trial: 3545108
Drug: Methimazole in
RxNorm normalized name: methimazole Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole in combination with thyroxine (Group I)
Trial: 12220761
Drug: Fluoxetine 10
RxNorm normalized name: fluoxetine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 10 mg
Trial: 11106133
Drug: Fluoxetine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (both doses)
Trial: 11417777
Drug: Intranasal nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal nicotine spray
Trial: 1855281
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg dexamethasone (i.v.)
Trial: 7049340
Drug: Lecithin and
RxNorm normalized name: Lecithin
DrugBank: Lecithin (DB15834)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lecithin and linoleic acid supplements
Trial: 17451577
Drug: Stacked double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stacked double pulses (single-pass treatment)
Trial: 17451577
Drug: Double-pass treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-pass treatment of single pulses
Trial: 11641361
Drug: Technegas inhalation
RxNorm normalized name: TECHNEGAS KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technegas inhalation during tidal breathing
Trial: 11641361
Drug: Inhaled methacholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled methacholine (dose sufficient to abolish expiratory flow reserve)
Trial: 11641361
Drug: Three increasing
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three increasing doses of methacholine
Trial: 9689551
Drug: Non-insulin-dependent diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-insulin-dependent diabetes mellitus patients with microalbuminuria
Trial: 7737258
Drug: Casodex (ICI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex (ICI 176,334) 50 mg/day
Trial: 7737258
Drug: Casodex (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex (100 and 150 mg/day)
Trial: 7737258
Drug: Casodex (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex (50 mg/day)
Trial: 134897
Drug: Alprenolol 400
RxNorm normalized name: alprenolol
DrugBank: Alprenolol (DB00866)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprenolol 400 mg daily
Trial: 23512255
Drug: New design
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New design implant
Trial: 23512255
Drug: Traditional implant
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional implant
Trial: 18086024
Drug: Probiotic lozenge
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lozenge with L. reuteri ATCC 55730/L. reuteri ATCC PTA 5289 (1.1 x 10(8) CFU) once daily for 10 days
Trial: 8462010
Drug: Epidoxorubicin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidoxorubicin 60 mg/m2 (group A)
Trial: 8462010
Drug: Epidoxorubicin 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidoxorubicin 120 mg/m2 (group B)
Trial: 2941697
Drug: Phenoterol administered
RxNorm normalized name: Phenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenoterol administered after ipratropium bromide
Trial: 2941697
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide administered before phenoterol
Trial: 29891834
Drug: Reduced-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose tacrolimus (4.51±1.62 ng/mL)
Trial: 29891834
Drug: Standard tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard tacrolimus dosage (6.75±2.82 ng/mL)
Trial: 27399077
Drug: EBV DNA
RxNorm normalized name: Toxoplasma gondii DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EBV DNA level >200 copies/mL
Trial: 16189173
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml 5% glucose solution infused over 30 min after achieving hypoglycemia
Trial: 16189173
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml isotonic saline infused over 30 min after achieving hypoglycemia
Trial: 10657578
Drug: HMG‐CoA reductase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG‐CoA reductase inhibitors in FH patients
Trial: 8866634
Drug: Brofaromine 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine 75 mg
Trial: 6741679
Drug: High nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High nicotine cigarettes (2.5 mg)
Trial: 6741679
Drug: Medium nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medium nicotine cigarettes (1.5 mg)
Trial: 6741679
Drug: Low nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low nicotine cigarettes (0.5 mg)
Trial: 29923286
Drug: PF-06291874 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06291874 (30 mg once daily)
Trial: 29923286
Drug: PF-06291874 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06291874 (60 mg once daily)
Trial: 29923286
Drug: PF-06291874 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06291874 (100 mg once daily)
Trial: 29923286
Drug: PF-06291874 (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06291874 (30, 60, or 100 mg once daily)
Trial: 27661415
Drug: Ivabradine 5mg
RxNorm normalized name: IVABRADINE 5MG TAB
DrugBank: Ivabradine (DB09083)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ivabradine 5mg twice a day
Trial: 24264372
Drug: Ibandronate (cumulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate (cumulative dose, 13.5 mg)
Trial: 22398753
Drug: Spread containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spread containing bioactive milk peptides IPP and VPP, and plant sterols (20 g day⁻¹ for 10 weeks)
Trial: 19815048
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (Ginko T.D. Tolidaru, Iran) at a dose of 80‐120 mg/day depending on weight (80 mg/day for <30 kg and 120 mg/day for >30 kg)
Trial: 19815048
Drug: Methylphenidate at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate at a dose of 20‐30 mg/day depending on weight (20 mg/day for <30 kg and 30 mg/day for >30 kg)
Trial: 378574
Drug: Rifampicin-trimethoprim combination
RxNorm normalized name: rifampin / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin-trimethoprim combination (450 mg plus 120 mg twice daily)
Trial: 378574
Drug: Rifampicin alone
RxNorm normalized name: rifampicin
DrugBank: Rifampin (DB01045)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifampicin alone (450 mg twice daily)
Trial: 378574
Drug: Rifampicin-trimethoprim combination
RxNorm normalized name: rifampin / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin-trimethoprim combination and rifampicin alone
Trial: 30906562
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg Nilotinib
Trial: 28323799
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics (PO)
Trial: 28323799
Drug: Intravenous antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotics (IV)
Trial: 21669016
Drug: Intranasal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal steroid plus per-oral vitamins A, C and E and selenium
Trial: 21669016
Drug: Intranasal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal steroid
Trial: 19155904
Drug: 1-day nitrofurantoin
RxNorm normalized name: Nitrofurantoin
DrugBank: Nitrofurantoin (DB00698)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 1-day nitrofurantoin regimen (100 mg capsules, taken twice daily for 1 day)
Trial: 19155904
Drug: 7-day nitrofurantoin
RxNorm normalized name: Nitrofurantoin
DrugBank: Nitrofurantoin (DB00698)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 7-day nitrofurantoin regimen (100 mg capsules, taken twice daily for 7 days)
Trial: 16716870
Drug: Ziconotide (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziconotide (0.1 microg/hour starting dose, titrated to a mean dose of 0.29 microg/hour)
Trial: 11571009
Drug: Medical feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical feedback vignette with medication change recommended
Trial: 11571009
Drug: Medical feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical feedback vignette with no medication change recommended
Trial: 9713464
Drug: GRA 1
RxNorm normalized name: Viagra 100mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GRA 1 mg + DEX 20 mg
Trial: 9713464
Drug: GRA 3
RxNorm normalized name: Allegra 30mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GRA 3 mg + DEX 20 mg
Trial: 31434809
Drug: Alirocumab (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab (75 mg every 2 weeks, up to 150 mg every 2 weeks)
Trial: 31434809
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (SoC; atorvastatin ≥10 mg/day or rosuvastatin ≥5 mg/day)
Trial: 26267590
Drug: Phenylephrine HCl
RxNorm normalized name: Phenylephrine HCl
DrugBank: Phenylephrine (DB00388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylephrine HCl 10 mg
Trial: 26267590
Drug: Phenylephrine HCl
RxNorm normalized name: Phenylephrine HCl
DrugBank: Phenylephrine (DB00388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylephrine HCl 20 mg
Trial: 26267590
Drug: Phenylephrine HCl
RxNorm normalized name: Phenylephrine HCl
DrugBank: Phenylephrine (DB00388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylephrine HCl 30 mg
Trial: 21222064
Drug: Rosuvastatin (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (2.5 mg daily)
Trial: 19695386
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl spray (INFS) 50 to 200 microg
Trial: 9626916
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times a day (tid)
Trial: 9626916
Drug: Orlistat (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (all doses)
Trial: 3299174
Drug: Weekly nonstress
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly nonstress testing (NST)
Trial: 3299174
Drug: NST plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NST plus weekly ultrasound evaluation
Trial: 26522611
Drug: Conventional once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional once‐daily morphologic embryo screening (CS)
Trial: 26522611
Drug: Conventional once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional once‐daily morphologic embryo screening (CS) with blastocyst transfers
Trial: 18781483
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen 0.625 mg
Trial: 9822087
Drug: Abciximab (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abciximab (bolus plus infusion)
Trial: 790946
Drug: Continuous high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous high-dose aspirin (ASA) for 14 days
Trial: 790946
Drug: Interrupted high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interrupted high-dose aspirin (ASA) for 14 days
Trial: 31587887
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg/d, orally
Trial: 28346154
Drug: Text message
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text message intervention (2 text messages outlining individualized bedtime goals daily for 8 weekdays)
Trial: 20934897
Drug: FPG and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FPG and HbA(1c) combination
Trial: 16689755
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg day(-1)
Trial: 16689755
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg day(-1)
Trial: 16689755
Drug: Fenofibrate 160
RxNorm normalized name: fenofibrate 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 160 mg day(-1)
Trial: 16689755
Drug: Quinapril 10
RxNorm normalized name: quinapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 10 mg day(-1)
Trial: 16689755
Drug: All drugs
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All drugs tested (including aspirin)
Trial: 15558071
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (33.3 mg m(‐2) for 6 weeks)
Trial: 15558071
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (75 mg m(‐2))
Trial: 15558071
Drug: Both weekly
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both weekly and 3-weekly docetaxel
Trial: 8493629
Drug: Salbutamol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (400 micrograms four times daily)
Trial: 8493629
Drug: Salbutamol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (400 micrograms twice daily)
Trial: 30636064
Drug: Four implants
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four implants in the posterior maxilla
Trial: 30636064
Drug: Six implants
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six implants in the posterior maxilla
Trial: 28560762
Drug: Desmopressin 25
RxNorm normalized name: desmopressin acetate 27.7 MCG (desmopressin 25 MCG) Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin 25 µg ODT + Tolterodine 4 mg (n=49)
Trial: 28560762
Drug: Tolterodine 4
RxNorm normalized name: tolterodine 4 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 4 mg (n=57)
Trial: 25362163
Drug: Metoprolol administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol administration
Trial: 11123825
Drug: Diethyl carbamazine
RxNorm normalized name: Diethyl Phthalate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethyl carbamazine (DEC) (6 mg/kg/body weight)
Trial: 8259846
Drug: Ftorafur (FT)
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ftorafur (FT) 600 mg/day for 2 years
Trial: 8259846
Drug: Ftorafur (FT)
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ftorafur (FT) 600 mg/day plus Tamoxifen (TAM) 20 mg/day for 2 years
Trial: 7579506
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 20 mg/day for 2 years
Trial: 3964494
Drug: Phosphate (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphate (1.5 g/day)
Trial: 3964494
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (Phosphate + Calcitonin)
Trial: 29239867
Drug: AZI/AML/HCTZ 20/5/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZI/AML/HCTZ 20/5/12.5 mg
Trial: 29239867
Drug: AZI/AML/HCTZ 20/5/6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZI/AML/HCTZ 20/5/6.25 mg
Trial: 29239867
Drug: AZI/AML 20/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZI/AML 20/5 mg
Trial: 12588577
Drug: HCTZ 12.5
RxNorm normalized name: HCTZ 12.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 12.5 mg
Trial: 29239867
Drug: HCTZ 6.25
RxNorm normalized name: BENAZEPRIL HCL 5/HCTZ 6.25MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 6.25 mg
Trial: 25549485
Drug: High-doses of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-doses of antithrombin III (AT)
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 1 mg iron/kg
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 2 mg iron/kg
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 4 mg iron/kg
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 4 mg iron/kg at injection rates of 90 mg/min
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 4 mg iron/kg at injection rates of 180 mg/min
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 4 mg iron/kg at injection rates of 1800 mg/min
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 125 mg over 5 min in hemodialysis patients
Trial: 16088081
Drug: Ferumoxytol at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferumoxytol at 250 mg over 5 min in hemodialysis patients
Trial: 7749431
Drug: Long protocol
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long protocol of gonadotropin releasing hormone agonist (GnRH‐a) administration
Trial: 7749431
Drug: Short protocol
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short protocol of gonadotropin releasing hormone agonist (GnRH‐a) administration
Trial: 575498
Drug: Creatinol O-phosphate
RxNorm normalized name: Padimate O
DrugBank: Padimate O (DB11570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatinol O-phosphate (COP) 3.06 g i.v./24 h for 3 days
Trial: 575498
Drug: Glucose-insulin-K+ (GIK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-insulin-K+ (GIK) for 3 days
Trial: 25556916
Drug: Paclitaxel/carboplatin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel/carboplatin plus sorafenib (400 mg orally twice daily)
Trial: 20350786
Drug: Neoadjuvant androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant androgen deprivation therapy (NADT) for 0, 3, or 6 months prior to and during radiation treatment at 66 Gy
Trial: 19476583
Drug: LDL cholesterol
RxNorm normalized name: LDL cholesterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL cholesterol <or=130 mg/dL
Trial: 19476583
Drug: LDL levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL levels between 131 and 159 mg/dL